The variety of cephalosporins 1 and 2 which possessed C (3)-aminopyrimidinyl substituents were prepared and evaluated for their antibacterial activities. They exhibited excellent in vitro activities especially against respiratory tract pathogens such as penicillin resistant Streptococcus pneumonia, Moraxella catarrhalis and Haemophilus influenza.